344 related articles for article (PubMed ID: 17716969)
1. The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy.
Eckermann K; Mocanu MM; Khlistunova I; Biernat J; Nissen A; Hofmann A; Schönig K; Bujard H; Haemisch A; Mandelkow E; Zhou L; Rune G; Mandelkow EM
J Biol Chem; 2007 Oct; 282(43):31755-65. PubMed ID: 17716969
[TBL] [Abstract][Full Text] [Related]
2. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.
Mocanu MM; Nissen A; Eckermann K; Khlistunova I; Biernat J; Drexler D; Petrova O; Schönig K; Bujard H; Mandelkow E; Zhou L; Rune G; Mandelkow EM
J Neurosci; 2008 Jan; 28(3):737-48. PubMed ID: 18199773
[TBL] [Abstract][Full Text] [Related]
3. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.
Hochgräfe K; Sydow A; Mandelkow EM
FEBS J; 2013 Sep; 280(18):4371-81. PubMed ID: 23517246
[TBL] [Abstract][Full Text] [Related]
4. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
Sydow A; Mandelkow EM
Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
[TBL] [Abstract][Full Text] [Related]
5. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.
Van der Jeugd A; Hochgräfe K; Ahmed T; Decker JM; Sydow A; Hofmann A; Wu D; Messing L; Balschun D; D'Hooge R; Mandelkow EM
Acta Neuropathol; 2012 Jun; 123(6):787-805. PubMed ID: 22532069
[TBL] [Abstract][Full Text] [Related]
6. Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs.
Khlistunova I; Biernat J; Wang Y; Pickhardt M; von Bergen M; Gazova Z; Mandelkow E; Mandelkow EM
J Biol Chem; 2006 Jan; 281(2):1205-14. PubMed ID: 16246844
[TBL] [Abstract][Full Text] [Related]
7. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant.
Sydow A; Van der Jeugd A; Zheng F; Ahmed T; Balschun D; Petrova O; Drexler D; Zhou L; Rune G; Mandelkow E; D'Hooge R; Alzheimer C; Mandelkow EM
J Neurosci; 2011 Feb; 31(7):2511-25. PubMed ID: 21325519
[TBL] [Abstract][Full Text] [Related]
8. Tauopathies and tau oligomers.
Takashima A
J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
[TBL] [Abstract][Full Text] [Related]
9. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
[TBL] [Abstract][Full Text] [Related]
10. Conformation determines the seeding potencies of native and recombinant Tau aggregates.
Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S
J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315
[TBL] [Abstract][Full Text] [Related]
11. Analysis of in vivo turnover of tau in a mouse model of tauopathy.
Yamada K; Patel TK; Hochgräfe K; Mahan TE; Jiang H; Stewart FR; Mandelkow EM; Holtzman DM
Mol Neurodegener; 2015 Oct; 10():55. PubMed ID: 26502977
[TBL] [Abstract][Full Text] [Related]
12. Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model.
Green C; Sydow A; Vogel S; Anglada-Huguet M; Wiedermann D; Mandelkow E; Mandelkow EM; Hoehn M
Mol Neurodegener; 2019 Mar; 14(1):13. PubMed ID: 30917861
[TBL] [Abstract][Full Text] [Related]
13. Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
Sydow A; Van der Jeugd A; Zheng F; Ahmed T; Balschun D; Petrova O; Drexler D; Zhou L; Rune G; Mandelkow E; D'Hooge R; Alzheimer C; Mandelkow EM
J Mol Neurosci; 2011 Nov; 45(3):432-7. PubMed ID: 21822709
[TBL] [Abstract][Full Text] [Related]
14. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
[TBL] [Abstract][Full Text] [Related]
15. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.
Terwel D; Lasrado R; Snauwaert J; Vandeweert E; Van Haesendonck C; Borghgraef P; Van Leuven F
J Biol Chem; 2005 Feb; 280(5):3963-73. PubMed ID: 15509565
[TBL] [Abstract][Full Text] [Related]
16. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
[TBL] [Abstract][Full Text] [Related]
17. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
18. Altered Proteostasis in Neurodegenerative Tauopathies.
Papanikolopoulou K; Skoulakis EMC
Adv Exp Med Biol; 2020; 1233():177-194. PubMed ID: 32274757
[TBL] [Abstract][Full Text] [Related]
19. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
[TBL] [Abstract][Full Text] [Related]
20. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
